New diabetes clinical trial: Fenofibrate Versus Curcumin in Type 2 Diabetic Patients

Published on: August 27, 2020 at 09:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Glimepiride Tablets;   Drug: glimepiride plus fenofibrate;   Drug: glimepiride plus curcumin
Sponsor:   Rehab Werida
Not yet recruiting
https://ift.tt/32LE16z